Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$1.56B |
| 2 |
Amazon
AMZN
|
+$1.34B |
| 3 |
Eli Lilly
LLY
|
+$1.26B |
| 4 |
NVIDIA
NVDA
|
+$1.08B |
| 5 |
Chevron
CVX
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$964M |
| 2 |
ANSS
Ansys
ANSS
|
+$924M |
| 3 |
Johnson & Johnson
JNJ
|
+$753M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$418M |
| 5 |
American Express
AXP
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.52% |
| 2 | Financials | 13.57% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Communication Services | 9.71% |
| 5 | Healthcare | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
LiqTech
LIQT
$20M
| $111K | ﹤0.01% |
42,137
-19,859
| -32% | -$42.2K |
|
4102
NextTrip
NTRP
$22.7M
| $111K | ﹤0.01% |
32,766
+18,975
| +138% | +$72.2K |
|
4103
Edesa Biotech
EDSA
$51.2M
| $110K | ﹤0.01% |
45,234
+17,278
| +62% | +$40K |
|
4104
Moleculin Biotech
MBRX
$3.27M
| $110K | ﹤0.01% |
8,328
+7,227
| +656% | +$97.6K |
|
|
PHOE
4105
Phoenix Asia Holdings
PHOE
$416M
| $110K | ﹤0.01% |
12,645
| – | – |
|
|
CODX
4106
Co-Diagnostics
CODX
$5.6M
| $110K | ﹤0.01% |
10,666
| – | – |
|
4107
Codere Online
CDRO
$408M
| $110K | ﹤0.01% |
15,902
+2,302
| +17% | +$18.6K |
|
|
VEEA
4108
Veea Inc
VEEA
$7.48M
| $109K | ﹤0.01% |
175,292
+1,251
| +0.7% | +$1.33K |
|
4109
Beasley Broadcasting Group
BBGI
$39.3M
| $109K | ﹤0.01% |
20,154
| – | – |
|
|
MIMI
4110
Mint Inc
MIMI
$14.4M
| $108K | ﹤0.01% |
1,379
| – | – |
|
4111
Healthcare Triangle
HCTI
$2.47M
| $108K | ﹤0.01% |
685
+683
| +34,150% | +$180K |
|
|
CYCU
4112
Cycurion Inc
CYCU
$7.1M
| $108K | ﹤0.01% |
9,211
+8,426
| +1,073% | +$79.2K |
|
4113
Ceragon Networks
CRNT
$201M
| $108K | ﹤0.01% |
46,357
| – | – |
|
4114
Retractable Technologies
RVP
$20.1M
| $108K | ﹤0.01% |
128,107
| – | – |
|
|
PCAP
4115
ProCap Acquisition Corp
PCAP
$327M
| $107K | ﹤0.01% |
+10,445
| New | +$108K |
|
|
LIMN
4116
Liminatus Pharma
LIMN
$7.2M
| $106K | ﹤0.01% |
63,734
-107
| -0.2% | -$462 |
|
|
LGVN
4117
Longeveron
LGVN
$24.1M
| $106K | ﹤0.01% |
141,501
| – | – |
|
4118
Matinas BioPharma
MTNB
$1.47M
| $106K | ﹤0.01% |
55,970
+476
| +0.9% | +$684 |
|
|
NTWO
4119
Newbury Street II Acquisition Corp
NTWO
| $105K | ﹤0.01% |
10,095
| – | – |
|
4120
ProQR Therapeutics
PRQR
$267M
| $104K | ﹤0.01% |
48,822
| – | – |
|
4121
KALA BIO
KALA
$16.7M
| $104K | ﹤0.01% |
1,358
+231
| +20% | +$115K |
|
|
FAC
4122
Factorial Energy Inc
FAC
$598M
| $104K | ﹤0.01% |
+10,319
| New | +$103K |
|
4123
Tandy Leather Factory
TLF
$20.5M
| $104K | ﹤0.01% |
34,174
+716
| +2% | +$2.32K |
|
|
KWM
4124
K Wave Media Ltd
KWM
$6.05M
| $103K | ﹤0.01% |
1,420
| – | – |
|
4125
Nocera
NCRA
$3.43M
| $102K | ﹤0.01% |
2,131
+107
| +5% | +$4.66K |
|
Similar funds
Geode Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Geode Capital Management held 4,592 positions worth $1.57T, up 9.9% from $1.43T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Geode Capital Management's Q3 2025 filing shows 148 new, 2,907 increased, 1,130 reduced and 119 closed positions. Its largest new stake was Paramount Skydance Corp: 8,343,504 shares worth $158M. The largest sale was Hess, an estimated $964M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geode Capital Management's largest Q3 2025 buy was Paramount Skydance Corp: 8,343,504 shares worth $158M.
- Geode Capital Management added most to Applovin in Q3 2025, an estimated $1.56B increase.
- Geode Capital Management's biggest Q3 2025 reduction was Johnson & Johnson, cutting an estimated $753M.
- Geode Capital Management fully exited Hess in Q3 2025, selling an estimated $964M.
- Geode Capital Management's ten largest holdings make up 34% of its $1.57T portfolio in Q3 2025.
- Geode Capital Management opened 148 new positions and closed 119 in Q3 2025.
- Geode Capital Management's portfolio value rose 9.9% quarter-over-quarter to $1.57T.
Based on Geode Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.